258 related articles for article (PubMed ID: 28831118)
1. Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer's disease progression.
Lachén-Montes M; González-Morales A; Zelaya MV; Pérez-Valderrama E; Ausín K; Ferrer I; Fernández-Irigoyen J; Santamaría E
Sci Rep; 2017 Aug; 7(1):9115. PubMed ID: 28831118
[TBL] [Abstract][Full Text] [Related]
2. Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.
Zelaya MV; Pérez-Valderrama E; de Morentin XM; Tuñon T; Ferrer I; Luquin MR; Fernandez-Irigoyen J; Santamaría E
Oncotarget; 2015 Nov; 6(37):39437-56. PubMed ID: 26517091
[TBL] [Abstract][Full Text] [Related]
3. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
[TBL] [Abstract][Full Text] [Related]
4. Tackling the Biological Meaning of the Human Olfactory Bulb Dyshomeostatic Proteome across Neurological Disorders: An Integrative Bioinformatic Approach.
Cartas-Cejudo P; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768771
[TBL] [Abstract][Full Text] [Related]
5. The olfactory bulb proteotype differs across frontotemporal dementia spectrum.
Lachén-Montes M; González-Morales A; Schvartz D; Zelaya MV; Ausin K; Fernández-Irigoyen J; Sánchez JC; Santamaría E
J Proteomics; 2019 Jun; 201():37-47. PubMed ID: 30999060
[TBL] [Abstract][Full Text] [Related]
6. Network-Driven Proteogenomics Unveils an Aging-Related Imbalance in the Olfactory IκBα-NFκB p65 Complex Functionality in Tg2576 Alzheimer's Disease Mouse Model.
Palomino-Alonso M; Lachén-Montes M; González-Morales A; Ausín K; Pérez-Mediavilla A; Fernández-Irigoyen J; Santamaría E
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29077059
[TBL] [Abstract][Full Text] [Related]
7. Unveiling the olfactory proteostatic disarrangement in Parkinson's disease by proteome-wide profiling.
Lachén-Montes M; González-Morales A; Iloro I; Elortza F; Ferrer I; Gveric D; Fernández-Irigoyen J; Santamaría E
Neurobiol Aging; 2019 Jan; 73():123-134. PubMed ID: 30342273
[TBL] [Abstract][Full Text] [Related]
8. Progressive modulation of the human olfactory bulb transcriptome during Alzheimer´s disease evolution: novel insights into the olfactory signaling across proteinopathies.
Lachen-Montes M; Zelaya MV; Segura V; Fernández-Irigoyen J; Santamaría E
Oncotarget; 2017 Sep; 8(41):69663-69679. PubMed ID: 29050232
[TBL] [Abstract][Full Text] [Related]
9. Early-Onset Molecular Derangements in the Olfactory Bulb of Tg2576 Mice: Novel Insights Into the Stress-Responsive Olfactory Kinase Dynamics in Alzheimer's Disease.
Lachen-Montes M; González-Morales A; Palomino M; Ausin K; Gómez-Ochoa M; Zelaya MV; Ferrer I; Pérez-Mediavilla A; Fernández-Irigoyen J; Santamaría E
Front Aging Neurosci; 2019; 11():141. PubMed ID: 31244650
[TBL] [Abstract][Full Text] [Related]
10. Amyotrophic Lateral Sclerosis Is Accompanied by Protein Derangements in the Olfactory Bulb-Tract Axis.
Lachén-Montes M; Mendizuri N; Ausin K; Andrés-Benito P; Ferrer I; Fernández-Irigoyen J; Santamaría E
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167591
[TBL] [Abstract][Full Text] [Related]
11. Olfactory Bulb Proteomics Reveals Widespread Proteostatic Disturbances in Mixed Dementia and Guides for Potential Serum Biomarkers to Discriminate Alzheimer Disease and Mixed Dementia Phenotypes.
Lachén-Montes M; Íñigo-Marco I; Cartas-Cejudo P; Fernández-Irigoyen J; Santamaría E
J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34204996
[TBL] [Abstract][Full Text] [Related]
12. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.
Mundiñano IC; Caballero MC; Ordóñez C; Hernandez M; DiCaudo C; Marcilla I; Erro ME; Tuñon MT; Luquin MR
Acta Neuropathol; 2011 Jul; 122(1):61-74. PubMed ID: 21553300
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid ameliorates olfactory dysfunction in APP/PS1 transgenic mice of Alzheimer's disease: Ameliorations from the olfactory epithelium to the olfactory bulb.
Yao ZG; Jing HY; Wang DM; Lv BB; Li JM; Liu FF; Fan H; Sun XC; Qin YJ; Zhao MQ
Pharmacol Biochem Behav; 2016 May; 144():53-9. PubMed ID: 26948859
[TBL] [Abstract][Full Text] [Related]
14. Distinct amyloid precursor protein processing machineries of the olfactory system.
Kim JY; Rasheed A; Yoo SJ; Kim SY; Cho B; Son G; Yu SW; Chang KA; Suh YH; Moon C
Biochem Biophys Res Commun; 2018 Jan; 495(1):533-538. PubMed ID: 29097202
[TBL] [Abstract][Full Text] [Related]
15. Progressive signaling changes in the olfactory nerve of patients with Alzheimer's disease.
Bathini P; Mottas A; Jaquet M; Brai E; Alberi L
Neurobiol Aging; 2019 Apr; 76():80-95. PubMed ID: 30708185
[TBL] [Abstract][Full Text] [Related]
16. Proteomic Analysis of the Human Olfactory Bulb.
Dammalli M; Dey G; Madugundu AK; Kumar M; Rodrigues B; Gowda H; Siddaiah BG; Mahadevan A; Shankar SK; Prasad TSK
OMICS; 2017 Aug; 21(8):440-453. PubMed ID: 28816642
[TBL] [Abstract][Full Text] [Related]
17. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
[TBL] [Abstract][Full Text] [Related]
18. Interneurons and beta-amyloid in the olfactory bulb, anterior olfactory nucleus and olfactory tubercle in APPxPS1 transgenic mice model of Alzheimer's disease.
Saiz-Sanchez D; De La Rosa-Prieto C; Ubeda-Bañon I; Martinez-Marcos A
Anat Rec (Hoboken); 2013 Sep; 296(9):1413-23. PubMed ID: 23904197
[TBL] [Abstract][Full Text] [Related]
19. Neuronal network-based biomimetic chip for long-term detection of olfactory dysfunction model in early-stage Alzheimer's disease.
Liu M; Chen C; Gao K; Gao F; Qin C; Yuan Q; Zhang H; Zhuang L; Wang P
Biosens Bioelectron; 2022 Nov; 216():114619. PubMed ID: 35986984
[TBL] [Abstract][Full Text] [Related]
20. Sex-divergent effects on the NAD+-dependent deacetylase sirtuin signaling across the olfactory-entorhinal-amygdaloid axis in Alzheimer's and Parkinson's diseases.
Cartas-Cejudo P; Lachén-Montes M; Ferrer I; Fernández-Irigoyen J; Santamaría E
Biol Sex Differ; 2023 Feb; 14(1):5. PubMed ID: 36755296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
